3 years 0
Extreme 0.0008
0.01
5 years 0
Extreme 0.0008
0.04
Manager TitleAgeSince
Chief Executive Officer 84 2020-05-31
Chief Operating Officer 72 2020-05-31
Chief Tech/Sci/R&D Officer 72 2021-05-03
Director TitleAgeSince
Chairman 84 2020-05-31
Director/Board Member 72 2020-05-31
Director/Board Member 56 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.11%+14.29%-69.23%-91.58% 0
-0.15%-3.99%+14.90%+184.91% 336B
-0.22%-1.55%+26.84%+161.62% 266B
+1.72%-2.34%+28.73%+545.63% 163B
-1.12%-0.21%+11.22%+24.51% 121B
+0.47%-0.97%+9.12%+62.00% 96.15B
+0.00%+0.77%-9.89%+21.74% 73.73B
-1.33%-2.99%-4.19%+81.63% 72.69B
-2.54%-4.20%-47.77%+289.85% 53.66B
+2.93%-1.71% - - 50.16B
Average -1.13%-1.72%-4.48%+142.26% 123.28B
Weighted average by Cap. -0.00%-2.21%+13.09%+191.30%
Logo HALBERD
Halberd Corporation is a technology holding company. The Company is focused on developing solutions for healthcare and medical applications. Its portfolio includes approaches to disease treatment, diagnostic technologies, and artificial intelligence (AI)-powered healthcare platforms. It has acquired licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid-related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its subsidiary, NeuroSense AI Corp., is a behavioral intelligence platform in development combining AI with multi-modal sensor technology that integrates ultrasonic vocalization analysis, micro-movement tracking, and social behavior monitoring through Claude AI-powered interpretation to provide unprecedented insights into brain health and recovery patterns. Its subsidiaries also include Alaric Corporation and Extendalife, Inc.
Employees
-
  1. Stock Market
  2. Stocks
  3. HALB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!